Annual Report

Overview

The report describes HUTCHMED's 2022 revenue growth to $426.4 million, supported by stronger Oncology/Immunology and Other Ventures performance. It highlights a four-tier sustainability governance framework with Board oversight, 11 new short-, medium- and long-term sustainability goals and targets, and sustainability-linked management KPIs. The company also completed a comprehensive stakeholder-supported materiality assessment and initiated climate-risk assessment leading to its first TCFD disclosures.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022
Period: Ends 31 December 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services